Clarity Pharmaceuticals (CU6.AU) Q3 2026 Earnings

27AugConfirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.15
-0.12
-0.1
-0.07

Details

Expected EPS
-0.1458188033643561
Actual EPS
-0.1201747638058814
Surprise EPS
0.03
Surprise Percent
+17.59%

Description

Clarity Pharmaceuticals (CU6.AU) has reported earnings of -0.1201747638058814 per share for Q3 2026.

0 Comments

Share your thoughts